INTRODUCTION
A cute pancreatitis is one of the main causes of hospitalization among benign diseases of digestive system, with an annual cost of two billion dollars in the US 1,2 . In the last ten years, it has been observed an increase of incidence and 20% of hospitalization. Severity of disease is associated to pancreatic or peri-pancreatic tissue necrosis, and the presence of infection is the most important factor for pancreatitis evolution 3 . Twenty per cent of patients present pancreatic necrosis and one third of this group have infection. In spite of modern intensive care treatments, mortality of infected pancreatic necrosis is almost 30% (12% to 39%), and, in the presence of multiple organ failure, may reach 70% 3-5 .
Therefore, infected pancreatic necrosis should not be considered a benign disease.
Infected pancreatic necrosis treatment experienced a great revolution in the past two decades6.
At first, all patients with infected necrosis will need an invasive procedure that may be performed by endoscopy, percutaneous access or surgery. In the past, surgery was the first or only option, but recent studies advocate Prophylactic antibiotics: are they still used?
The use of antibiotic prophylaxis is being studied and discussed in literature. The first studies in the nineties suggested that prophylactic use of antibiotics lowered the incidence of pancreatic necrosis infection and mortality. However, the methodology quality of those studies are questionable 15, 16 . More recent randomized studies did not confirm the initial data. Dellinger et al. 17 conducted a multicenter study and evaluated 100 patients with severe acute pancreatitis that were divided into two groups: placebo and use of meropenem. Infection was observed in 18% of patients of treated group, and in 12% of patients that received placebo. Surgery was necessary in 26% of those treated with antibiotics and in 20% of those treated with placebo. There was no difference of mortality. Garcia-Barrasa et al. 18 evaluated the use of ciprofloxacin for infection prophylaxis of pancreatic necrosis and also did not observe difference of mortality or of necrosis infection.
Therefore, the use of antibiotics in pancreatic necrosis must be restricted to patients with diagnosed infection, that usually occurs after the third week. Most used antibiotics are those with good penetration in the
Percutaneous Drainage
Open pancreatic necrosectomy is a significant surgical trauma for many critically ill patients. Since morbidity (34% to 95%), mortality (13% to 39%) and pancreatic insufficiency due to the procedure are high, in the last two decades some authors proposed a less invasive treatment 13, 19, 20 . Freeny et al. 21 A recent study observed that 88% of surgeons perform drainage before fourth week 14 .
It is discussed the role of rinsing after percutaneous drainage, the size of the drain and the possible advantage to change to progressively larger drains. Percutaneous drainage modified the evolution of pancreatitis, due to its capacity to resolve infection and multiple organ failure.
Predictive factors of success of percutaneous drainage
Success of percutaneous drainage is directly Babu et al. 23 showed that percutaneous drainage reverted sepsis in 62% of patients and 48% did not need necrosectomy. These authors described a high rate of success with only drainage, in relation to others in literature. They believe that the reason is the extensive rinsing of abdominal cavity with saline to remove debris. They indicate as predictive factors for success of drainage: sepsis resolution, APACHE II levels at the procedure and multiple organ failure in the first week of pancreatitis.
Hollemans et al. 24 Bakker et al. 27 performed the first randomi- 
Which is the best moment for drainage or necrosectomy?
The timing of surgical intervention in pancreatic necrosis has changed over the last two decades.
Götzinger et al. 29 showed mortality of 46% of patients submitted to surgery during the first three weeks of the beginning of the disease, versus 25% after this period.
Rodriguez et al. 13 Grinsven et al. 14 proposed a question form about the best moment for drainage in infected pancreatic necrosis. They observed that 55% of interviewees postpone drainage after the diagnosis of infection, but 45% adopt immediate drainage. In this study, 87%
of interviewees advocate the use of step up approach. 
Open or minimally invasive necrosectomy
Open necrosectomy was considered the main treatment for decades, but with therapeutic minimally invasive improvements, it was observed a change of concepts. The reason was the need to reduce morbidity of procedure, that is performed in already frail pa- 
Is there a role for non-surgical treatment?
Exclusive clinical treatment or with minimally invasive procedures avoids surgical complications, such as worsening of multiple organ failure, pancreatic insufficiency and incisional hernia 34 . Runzi et al. 43 published the first big series of non-surgical treatment of infected pancreatic necrosis. They evaluated 28 patients, and, among these, 16 were not operated. The others presented multiple organ failure. Mortality was 12.5%. it must be pointed out that in that work, only three patients were submitted to percutaneous drainage, although ten presented worsening of clinical condition. Lee et al. 44 also described non-surgical treatment. They treated eight patients exclusively with antibiotics. Rasslan et al. 45 presented a series of six patients with necrosis and gas in the retroperitoneum treated exclusively with antibiotics.
We believe that, in the beginning of disease, treatment must be made only with antibiotics, but in the presence of worsening of clinical conditions, some intervention must be made.
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CONCLUSIONS
Infected pancreatic necrosis treatment must be made by a multidisciplinary team including surgeon, intensive care specialist, radiologist and endoscopic surgeon. Only referral centers have conditions to treat this disease. When we review the treatment of infected acute pancreatitis in the last two decades, it is observed an extraordinary evolution. We do not operate as many times as before, scheduled reoperations are no longer used, new resources are available, as those here described, and a significant reduction of morbidity and mortality rates was achieved. There is no mandatory procedure to be made initially or as best option. The use of the step-up approach and postponing the drainage must be adopted in all patients. In those with infection, even with gas in retroperitoneum, it is possible to use only antibiotics with good results, in patients without multiple organ failure.
Minimally invasive treatment with drainage may be the first alternative, but evolution, clinical condition and pancreatic necrosis characteristics will define the best technique to be used. Literature presents high rates of success with minimally invasive drainage, but, when infection is not reverted, open necrosectomy must be considered.
